Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
11,640,376
-
Share change
-
+4,539,476
-
Total reported value
-
$80,287,912
-
Put/Call ratio
-
9%
-
Price per share
-
$6.90
-
Number of holders
-
47
-
Value change
-
+$31,815,255
-
Number of buys
-
33
-
Number of sells
-
12
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2014
As of 31 Mar 2014,
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,640,376 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, BRIDGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Fund Advisors, JENNISON ASSOCIATES LLC, COLUMBUS CIRCLE INVESTORS, NORTHERN TRUST CORP, State Street Corp, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.